Scientific Posters

Potency Assay Development for Gene Therapy Products – Approaches and Points to Consider in Data Processing

  • PDF (757.98 KB)

Gene therapies – including AAVs, engineered viruses and polymer formulated oligonucleotides/plasmids – are among the highest growth area in biopharmaceuticals.

Find Out More

Toxicokinetics of Pirfenidone in Dogs Following Inhalation in a Nebulized Aerosol Formulation

  • PDF (25.99 MB)

To assess the toxicokinetics (TK) exposure of pirfenidone (AP01) during a 28-day oronasal dog inhalation toxicity study

Find Out More

Comparison of the Pharmacokinetics of Four Different Dose- Frequency Combinations of AMZ001 (Diclofenac Gel 3.06%) with Voltaren® (Diclofenac Gel 1%) in Healthy Subjects in a Phase 1 Study

  • PDF (25.61 MB)

To evaluate how the steady state levels of AMZ001 applied one or two times daily compare to Voltaren® applied four times daily in healthy subjects.

Find Out More

Efficient and Economical Preclinical Pharmacokinetic Analyses for Human Therapeutic Antibodies and Constructs, Using a Validated Human Immunoglobulin Immunoassay in Plasma of Mice, Rats, and Monkeys

  • PDF (27.83 MB)

This work was conducted to develop and validate (fit-for-purpose, FFP) an efficient means for pharmacokinetic (PK) analyses of large molecule drugs composed in part, or…

Find Out More

Pirfenidone and its Metabolites 5-Carboxy-Pirfenidone and 5-Hydroxy-Pirfenidone Toxicokinetics in Rats Following Inhalation of a Nebulized Aerosol Formulation

  • PDF (26.83 MB)

To assess the toxicokinetics (TK) of pirfenidone (AP01) and its main metabolites 5-carboxy-pirfenidone and 5-hydroxy-pirfenidone during a 26-week oronasal rat inhalation toxicity study.

Find Out More

Design Of Total Anti-Vegf Assay Provides Simple Data Interpretation Of Anti-Vegf Therapeutic Study

  • PDF (28.03 MB)

Vascular Endothelial Growth Factor (VEGF) is an angiogenic factor associated with an array of diseases, including several cancers and retinopathy, making this protein both a…

Find Out More

Determination of Mifepristone in Human Plasma by Automated On-Line SPE Combined with MS/MS

  • PDF (24.97 MB)

Mifepristone is a synthetic steroid compound that has been studied in Phase II clinical trials for many medical uses, including: oral contraception, uterine fibroids, endometriosis

Find Out More

Embryo-Fetal Developmental Toxicokinetic Study of CBX129801, a Bio-active C-peptide for Potential Replacement Therapy in Type 1 Diabetic Nephropathy, in Rats and Rabbits After Subcutaneous Injections

  • PDF (26.59 MB)

To evaluate the maternal toxicokinetics and fetal exposures of CBX129801 in studies which assessed the developmental toxicity, after subcutaneous injection for 4 doses to pregnant…

Find Out More

Phase 1 Pharmacokinetic (PK) Assessment of ATI-1123, a Novel Human Serum Albumin-Stabilized Nanoparticle Docetaxel Liposomal Formulation, in Patients with Advanced Solid Malignancies

  • PDF (30.11 MB)

ATI-1123, a novel nanoparticle docetaxel liposomal formulation, is being investigated in patients (pts) with advanced solid malignancies. ATI-1123 is expected to reduce hypersensitivity reactions, have…

Find Out More

Toxicokinetics and Immunogenicity of CBX129801, a Pegylated C-Peptide Drug for Type 1 Diabetes Replacement Therapy, in Sprague Dawley Rats

  • PDF (25.20 MB)

To assess toxicokinetics (TK) and immunogenicity of CBX129801 in rats after subcutaneous (SC) injections for 4 weeks (5 doses) with 4-week recovery period.

Find Out More